Hypochlorous acid via peroxynitrite activates protein kinase Cθ and insulin resistance in adipocytes

Jun Zhou1, Qilong Wang1, Ye Ding1

  • 1Section of Molecular MedicineBSEB 306A, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.

Insights

Myeloperoxidase (MPO) product hypochlorous acid (HOCl) impairs insulin sensitivity in fat cells. HOCl activates PKCθ, leading to IKK/JNK and IRS1 phosphorylation, causing insulin resistance.

Area of Science:

  • Metabolism and Endocrinology
  • Cellular Biology
  • Biochemistry

Background:

  • Genetic deletion of myeloperoxidase (MPO) improves obesity-related insulin resistance in mice.
  • The precise mechanism by which MPO impairs insulin sensitivity in adipocytes remains unclear.
  • Hypochlorous acid (HOCl), an MPO-generated oxidant, is investigated for its role in insulin resistance.

Purpose of the Study:

  • To elucidate the effects of HOCl on insulin signaling pathways in adipocytes.
  • To investigate the molecular mechanisms linking HOCl to insulin resistance in adipose tissue.

Main Methods:

  • 3T3-L1 adipocytes were exposed to exogenous HOCl.
  • Insulin signaling, glucose uptake, and GLUT4 translocation were assessed.
  • Involvement of PKCθ, IKK, JNK, and IRS1 phosphorylation was analyzed using genetic and pharmacological approaches.
  • Peroxynitrite (ONOO(-)) activation and high-fat diet (HFD) models were employed.

Main Results:

  • HOCl treatment attenuated insulin-stimulated glucose uptake, GLUT4 translocation, and key insulin signaling proteins (Akt, IRS1).
  • HOCl induced phosphorylation of IRS1 at serine 307, IKK, JNK, and PKCθ.
  • Inhibition of IKK, JNK, or PKCθ, or ONOO(-), ameliorated HOCl-induced insulin resistance.
  • HFD-induced insulin resistance in mice showed increased phosphorylation of PKCθ, IKK, JNK, and IRS1-serine 307, which was absent in Mpo knockout mice.

Conclusions:

  • HOCl impairs insulin signaling in adipocytes by promoting ONOO(-) mediated phosphorylation of PKCθ.
  • This activation triggers a cascade involving IKK/JNK phosphorylation, leading to IRS1 serine phosphorylation and subsequent insulin resistance.
  • Targeting the MPO-HOCl-PKCθ pathway may offer therapeutic strategies for managing insulin resistance.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2